Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
about
Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cellsMolecular biology of lung cancer: clinical implicationsReplacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responsesMutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomasH-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signalingSmoking, p53 mutation, and lung cancerExpression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patientsEffect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeOncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cellsA genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignanciesCDDO-Me protects normal lung and breast epithelial cells but not cancer cells from radiationIdentification of a candidate therapeutic autophagy-inducing peptidePolymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancersThe biological sense of cancer: a hypothesisMultiple cancer testis antigens function to support tumor cell mitotic fidelity.Two subunits of human ORC are dispensable for DNA replication and proliferation.Inhibition of breast cancer metastasis suppressor 1 promotes a mesenchymal phenotype in lung epithelial cells that express oncogenic K-RasV12 and loss of p53.Transcriptional profiling of non-small cell lung cancer cells with activating EGFR somatic mutations.Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells.Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells.Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinomaNeuroD1 mediates nicotine-induced migration and invasion via regulation of the nicotinic acetylcholine receptor subunits in a subset of neural and neuroendocrine carcinomas.AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancerCytoglobin, the newest member of the globin family, functions as a tumor suppressor geneEpidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalizedMechanisms of Cancer Induction by Tobacco-Specific NNK and NNN.PIK3CA mutations and copy number gains in human lung cancers.Mechanisms promoting escape from mitotic stress-induced tumor cell death.Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas.Branching morphogenesis of immortalized human bronchial epithelial cells in three-dimensional culture.Multipotent capacity of immortalized human bronchial epithelial cellsRas transformation uncouples the kinesin-coordinated cellular nutrient responseMicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCsEpidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistanceSMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent mannerhnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processingSuppression of TET1-dependent DNA demethylation is essential for KRAS-mediated transformation.Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a.
P2860
Q24603941-6A2E01D2-EC8D-4062-A57E-1682B8A85732Q24610335-B4854193-CD2B-4553-9FCE-3358EE8519CEQ24658420-1B0120BF-62F5-4CFA-93D2-B26A4AF0DE04Q24669579-CA2E032F-88E0-46C9-A6B2-F5A21086AA90Q24671049-71B5A304-2174-45E5-89F7-8604FF50C480Q27014977-D4CA772C-B154-4CCC-92A1-9CAADE76BB6AQ27308972-A52B671D-95DC-4F56-8892-475540BC4DBAQ27851703-8C3A4933-49F8-491E-8965-370FEDFF966EQ28301952-901BD005-5067-45CD-8C57-1C7319156A1BQ28395771-88107A04-DBED-44AD-A95E-1E5C2B8D4F84Q28469084-D4927523-90E7-44A9-B11B-BFBE2B48ED0AQ28542835-DE658CC2-8F46-4C52-A2D4-841798599835Q28593490-3C93AB6E-2264-4A9A-A373-29B9DEAFC4F6Q28757672-C2DD76AE-6B87-4CFC-AFF0-B5393352D152Q28763945-0C25AA27-FA9E-4865-AA47-2A81A1D4487DQ29871492-B4FE6F19-A2DD-48BC-822B-E7E9D895F040Q30275323-914E2AC8-B6AC-48FC-A19D-BCD6623B125CQ30413635-A18B33E5-5CEF-40F8-9247-E5A5F5243BABQ33306709-7E43F9CD-62D6-4CE5-A188-E53F82867134Q33479152-CE6B6B9F-3F5E-460D-889E-9C1ADFF744CDQ33510334-DA3EE7AC-AD96-475D-89CD-0E71ADAB910AQ33631023-49CDF150-914B-4475-8F54-49D3F2807EA0Q33644421-C54E0E39-4D79-48B7-B4DE-5A3B1155103AQ33685667-5DEF2BFA-81E6-4A89-86B3-6D3A3F6614F3Q33750741-7E2AE5B9-7C9E-4FA6-BAC9-2F3863DDA83AQ33769833-8B6FE1DE-3755-4CCB-8837-25964EB67B8AQ33779882-5534885B-1FD4-456C-8313-65DB9A56EF76Q33820316-CCFB2185-D776-4A7B-AA31-063601E8DAE5Q33870342-73FC30B7-CC64-45A7-8A50-2B090B0ADCCEQ33916735-42A2527E-1378-43D7-9919-8630BE06CB3EQ33921360-5AC28E06-56AD-404B-89BB-E2C3ACFEA258Q33954342-61AC7BA3-226A-4477-A5F8-99AF020BAA0DQ33961710-09FE6532-7923-468A-846D-13A178DF929BQ33972110-E5FB989D-535C-4082-820C-EC36D851444CQ34008617-C2F8A38C-63C1-4545-9886-68839D8D52DBQ34105339-96708B69-6370-4B89-A814-C44928453B7FQ34229779-660AA9DB-91A9-4358-AFF2-C12FD68F733AQ34245430-8F5F3192-D363-4CB8-9FE0-9B95B1CEB0DAQ34451594-0714CC61-BAEF-401F-A808-7CB00E6BD8C7Q34685905-887F3548-4B14-48F2-80E3-5302794A4C56
P2860
Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Multiple oncogenic changes (K- ...... an bronchial epithelial cells.
@en
Multiple oncogenic changes (K- ...... an bronchial epithelial cells.
@nl
type
label
Multiple oncogenic changes (K- ...... an bronchial epithelial cells.
@en
Multiple oncogenic changes (K- ...... an bronchial epithelial cells.
@nl
prefLabel
Multiple oncogenic changes (K- ...... an bronchial epithelial cells.
@en
Multiple oncogenic changes (K- ...... an bronchial epithelial cells.
@nl
P2093
P1433
P1476
Multiple oncogenic changes (K- ...... man bronchial epithelial cells
@en
P2093
Adi F Gazdar
David S Shames
Jerry W Shay
John D Minna
Luc Girard
Michael Peyton
Mitsuo Sato
Noriaki Sunaga
Ruben D Ramirez
Woochang Lee
P304
P356
10.1158/0008-5472.CAN-05-2521
P407
P577
2006-02-01T00:00:00Z